The role of the inhibitors of interleukin-6 signal transduction SHP2 and SOCS3 for desensitization of interleukin-6 signalling

Patrick Fischer, Ute Lehmann, Radoslaw M. Sobota, Jochen Schmitz, Claudia Niemand, Sonja Linnemann, Serge Haan, Iris Behrmann, Akihiko Yoshimura, James A. Johnston, Gerhard Müller-Newen, Peter C. Heinrich, Fred Schaper

Research output: Contribution to journalArticle

59 Citations (Scopus)

Abstract

The immediate early response of cells treated with IL-6 (interleukin-6) is the activation of the signal transducer and activator of transcription (STAT)3. The Src homology domain 2 (SH2)-containing protein tyrosine phosphatase SHP2 and the feedback inhibitor SOCS3 (suppressor of cytokine signalling) are potent inhibitors of IL-6 signal transduction. Impaired function of SOCS3 or SHP2 leads to enhanced and prolonged IL-6 signalling. The inhibitory function of both proteins depends on their recruitment to the tyrosine motif 759 within glycoprotein gp130. In contrast to inactivation, desensitization of signal transduction is regarded as impaired responsiveness due to prestimulation. Usually, after activation the sensing receptor becomes inactivated by modifications such as phosphorylation, internalization or degradation. We designed an experimental approach which allows discrimination between desensitization and inactivation of IL-6 signal transduction. We observed that pre-stimulation with IL-6 renders cells less sensitive to further stimulation with IL-6. After several hours, the cells become sensitive again. We show that not only signal transduction through previously activated receptors is affected by desensitization but signalling through receptors which were not targeted by the first stimulation was also attenuated (transdesensitization). Interestingly, in contrast to inhibition, desensitization does not depend on the presence of functional SHP2. Furthermore, cells lacking SOCS3 show constitutive STAT3 activation which is not affected by pre-stimulation with IL-6. All these observations suggest that desensitization and inhibition of signalling are mechanistically distinct.

Original languageEnglish
Pages (from-to)449-460
Number of pages12
JournalBiochemical Journal
Volume378
Issue number2
DOIs
Publication statusPublished - 2004 Mar 1
Externally publishedYes

Fingerprint

Signal transduction
Interleukin-6
Signal Transduction
Chemical activation
STAT3 Transcription Factor
Phosphorylation
Protein Tyrosine Phosphatases
src Homology Domains
Tyrosine
Glycoproteins
Cytokines
Feedback
Degradation

Keywords

  • Inflammation
  • Interleukin-6
  • Signal transducer and activator of transcription 3 (STAT3)
  • Signal transduction
  • Src homology domain 2-containing protein tyrosine phosphatase (SHP2)
  • Suppressor of cytokine signalling 3 (SOCS3)

ASJC Scopus subject areas

  • Biochemistry

Cite this

Fischer, P., Lehmann, U., Sobota, R. M., Schmitz, J., Niemand, C., Linnemann, S., ... Schaper, F. (2004). The role of the inhibitors of interleukin-6 signal transduction SHP2 and SOCS3 for desensitization of interleukin-6 signalling. Biochemical Journal, 378(2), 449-460. https://doi.org/10.1042/BJ20030893

The role of the inhibitors of interleukin-6 signal transduction SHP2 and SOCS3 for desensitization of interleukin-6 signalling. / Fischer, Patrick; Lehmann, Ute; Sobota, Radoslaw M.; Schmitz, Jochen; Niemand, Claudia; Linnemann, Sonja; Haan, Serge; Behrmann, Iris; Yoshimura, Akihiko; Johnston, James A.; Müller-Newen, Gerhard; Heinrich, Peter C.; Schaper, Fred.

In: Biochemical Journal, Vol. 378, No. 2, 01.03.2004, p. 449-460.

Research output: Contribution to journalArticle

Fischer, P, Lehmann, U, Sobota, RM, Schmitz, J, Niemand, C, Linnemann, S, Haan, S, Behrmann, I, Yoshimura, A, Johnston, JA, Müller-Newen, G, Heinrich, PC & Schaper, F 2004, 'The role of the inhibitors of interleukin-6 signal transduction SHP2 and SOCS3 for desensitization of interleukin-6 signalling', Biochemical Journal, vol. 378, no. 2, pp. 449-460. https://doi.org/10.1042/BJ20030893
Fischer, Patrick ; Lehmann, Ute ; Sobota, Radoslaw M. ; Schmitz, Jochen ; Niemand, Claudia ; Linnemann, Sonja ; Haan, Serge ; Behrmann, Iris ; Yoshimura, Akihiko ; Johnston, James A. ; Müller-Newen, Gerhard ; Heinrich, Peter C. ; Schaper, Fred. / The role of the inhibitors of interleukin-6 signal transduction SHP2 and SOCS3 for desensitization of interleukin-6 signalling. In: Biochemical Journal. 2004 ; Vol. 378, No. 2. pp. 449-460.
@article{2f3592a5d8d54fc4876b86d43cd145bc,
title = "The role of the inhibitors of interleukin-6 signal transduction SHP2 and SOCS3 for desensitization of interleukin-6 signalling",
abstract = "The immediate early response of cells treated with IL-6 (interleukin-6) is the activation of the signal transducer and activator of transcription (STAT)3. The Src homology domain 2 (SH2)-containing protein tyrosine phosphatase SHP2 and the feedback inhibitor SOCS3 (suppressor of cytokine signalling) are potent inhibitors of IL-6 signal transduction. Impaired function of SOCS3 or SHP2 leads to enhanced and prolonged IL-6 signalling. The inhibitory function of both proteins depends on their recruitment to the tyrosine motif 759 within glycoprotein gp130. In contrast to inactivation, desensitization of signal transduction is regarded as impaired responsiveness due to prestimulation. Usually, after activation the sensing receptor becomes inactivated by modifications such as phosphorylation, internalization or degradation. We designed an experimental approach which allows discrimination between desensitization and inactivation of IL-6 signal transduction. We observed that pre-stimulation with IL-6 renders cells less sensitive to further stimulation with IL-6. After several hours, the cells become sensitive again. We show that not only signal transduction through previously activated receptors is affected by desensitization but signalling through receptors which were not targeted by the first stimulation was also attenuated (transdesensitization). Interestingly, in contrast to inhibition, desensitization does not depend on the presence of functional SHP2. Furthermore, cells lacking SOCS3 show constitutive STAT3 activation which is not affected by pre-stimulation with IL-6. All these observations suggest that desensitization and inhibition of signalling are mechanistically distinct.",
keywords = "Inflammation, Interleukin-6, Signal transducer and activator of transcription 3 (STAT3), Signal transduction, Src homology domain 2-containing protein tyrosine phosphatase (SHP2), Suppressor of cytokine signalling 3 (SOCS3)",
author = "Patrick Fischer and Ute Lehmann and Sobota, {Radoslaw M.} and Jochen Schmitz and Claudia Niemand and Sonja Linnemann and Serge Haan and Iris Behrmann and Akihiko Yoshimura and Johnston, {James A.} and Gerhard M{\"u}ller-Newen and Heinrich, {Peter C.} and Fred Schaper",
year = "2004",
month = "3",
day = "1",
doi = "10.1042/BJ20030893",
language = "English",
volume = "378",
pages = "449--460",
journal = "Biochemical Journal",
issn = "0264-6021",
publisher = "Portland Press Ltd.",
number = "2",

}

TY - JOUR

T1 - The role of the inhibitors of interleukin-6 signal transduction SHP2 and SOCS3 for desensitization of interleukin-6 signalling

AU - Fischer, Patrick

AU - Lehmann, Ute

AU - Sobota, Radoslaw M.

AU - Schmitz, Jochen

AU - Niemand, Claudia

AU - Linnemann, Sonja

AU - Haan, Serge

AU - Behrmann, Iris

AU - Yoshimura, Akihiko

AU - Johnston, James A.

AU - Müller-Newen, Gerhard

AU - Heinrich, Peter C.

AU - Schaper, Fred

PY - 2004/3/1

Y1 - 2004/3/1

N2 - The immediate early response of cells treated with IL-6 (interleukin-6) is the activation of the signal transducer and activator of transcription (STAT)3. The Src homology domain 2 (SH2)-containing protein tyrosine phosphatase SHP2 and the feedback inhibitor SOCS3 (suppressor of cytokine signalling) are potent inhibitors of IL-6 signal transduction. Impaired function of SOCS3 or SHP2 leads to enhanced and prolonged IL-6 signalling. The inhibitory function of both proteins depends on their recruitment to the tyrosine motif 759 within glycoprotein gp130. In contrast to inactivation, desensitization of signal transduction is regarded as impaired responsiveness due to prestimulation. Usually, after activation the sensing receptor becomes inactivated by modifications such as phosphorylation, internalization or degradation. We designed an experimental approach which allows discrimination between desensitization and inactivation of IL-6 signal transduction. We observed that pre-stimulation with IL-6 renders cells less sensitive to further stimulation with IL-6. After several hours, the cells become sensitive again. We show that not only signal transduction through previously activated receptors is affected by desensitization but signalling through receptors which were not targeted by the first stimulation was also attenuated (transdesensitization). Interestingly, in contrast to inhibition, desensitization does not depend on the presence of functional SHP2. Furthermore, cells lacking SOCS3 show constitutive STAT3 activation which is not affected by pre-stimulation with IL-6. All these observations suggest that desensitization and inhibition of signalling are mechanistically distinct.

AB - The immediate early response of cells treated with IL-6 (interleukin-6) is the activation of the signal transducer and activator of transcription (STAT)3. The Src homology domain 2 (SH2)-containing protein tyrosine phosphatase SHP2 and the feedback inhibitor SOCS3 (suppressor of cytokine signalling) are potent inhibitors of IL-6 signal transduction. Impaired function of SOCS3 or SHP2 leads to enhanced and prolonged IL-6 signalling. The inhibitory function of both proteins depends on their recruitment to the tyrosine motif 759 within glycoprotein gp130. In contrast to inactivation, desensitization of signal transduction is regarded as impaired responsiveness due to prestimulation. Usually, after activation the sensing receptor becomes inactivated by modifications such as phosphorylation, internalization or degradation. We designed an experimental approach which allows discrimination between desensitization and inactivation of IL-6 signal transduction. We observed that pre-stimulation with IL-6 renders cells less sensitive to further stimulation with IL-6. After several hours, the cells become sensitive again. We show that not only signal transduction through previously activated receptors is affected by desensitization but signalling through receptors which were not targeted by the first stimulation was also attenuated (transdesensitization). Interestingly, in contrast to inhibition, desensitization does not depend on the presence of functional SHP2. Furthermore, cells lacking SOCS3 show constitutive STAT3 activation which is not affected by pre-stimulation with IL-6. All these observations suggest that desensitization and inhibition of signalling are mechanistically distinct.

KW - Inflammation

KW - Interleukin-6

KW - Signal transducer and activator of transcription 3 (STAT3)

KW - Signal transduction

KW - Src homology domain 2-containing protein tyrosine phosphatase (SHP2)

KW - Suppressor of cytokine signalling 3 (SOCS3)

UR - http://www.scopus.com/inward/record.url?scp=12144290834&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=12144290834&partnerID=8YFLogxK

U2 - 10.1042/BJ20030893

DO - 10.1042/BJ20030893

M3 - Article

VL - 378

SP - 449

EP - 460

JO - Biochemical Journal

JF - Biochemical Journal

SN - 0264-6021

IS - 2

ER -